Adicet Bio (ACET) Other financing activities (2018 - 2025)

Adicet Bio (ACET) posted quarterly Other financing activities of $1000.0 for Q4 2025, up 100.37% quarter-over-quarter from -$267000.0 in Q3 2025.

Adicet Bio (ACET) Other financing activities (2018 - 2025) Analysis & Trends

Adicet Bio's Other financing activities history runs 8 years deep, the most recent figure standing at $1000.0 for Q4 2025.

In Q4 2025, Other financing activities changed N/A year-over-year to $1000.0; the TTM figure through Dec 2025 stood at $1000.0 (down 100.0% YoY), while the FY2025 annual figure was $1000.0, down 100.0% from the prior year.
Other financing activities for Q4 2025 stood at $1000.0, up from -$267000.0 in the prior quarter.
The five-year high for Other financing activities was $91.5 million in Q3 2024, with the low at -$976000.0 in Q2 2021.
The 5-year median for Other financing activities is $129000.0 (2021), against an average of $5.4 million.
The sharpest annual moves came in 2021 and 2024: Other financing activities plunged 14042.86% in 2021, then jumped 40546.22% in 2024.
Adicet Bio's Other financing activities stood at $129000.0 in 2021, then tumbled by 127.91% to -$36000.0 in 2022, then jumped by 536.11% to $157000.0 in 2023, then soared by 58150.96% to $91.5 million in 2024, then tumbled by 100.0% to $1000.0 in 2025.
Business Quant data shows ACET's Other financing activities at $1000.0 in Q4 2025, -$267000.0 in Q3 2025, and $267000.0 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.50 Bn	131.65 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	86.10 Bn	78.10 Bn	3.93 Bn
3	Argenx Se	65.59 Bn	60.41 Bn	1.37 Bn
4	Moderna	56.75 Bn	51.62 Bn	52.00 Mn
5	BeOne Medicines	42.11 Bn	37.01 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.64 Bn	28.33 Bn	992.69 Mn
7	BioNTech SE	27.80 Bn	9.41 Bn	668.28 Mn
8	Insmed	27.51 Bn	26.35 Bn	358.27 Mn
9	Royalty Pharma	27.29 Bn	26.45 Bn	-
10	Adicet Bio	100.36 Mn	-17.83 Mn	-

Download Data